Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

Advanced therapy medicinal products (ATMPs) are pushing the boundaries of medicine, offering hope for previously untreatable ...

What’s behind the dip in investment in the gene therapy sector? As promising as gene therapies are, one of the main issues for investors is that these types of treatments come with a lot of risk and, ...

Glassdoor, Payscale, or more specifically BioPharmGuy (to look through a large variety of job offers similar to yours) are ...